Cardiovascular disease risk reduction in the Behavioral Risk Factor Surveillance System

American Journal of Preventive Medicine

Volumn 27, Issue 1, 2004, Pages 1-7

  Kim, Catherine ^a   Beckles, Gloria L ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; LIPID;

ADULT; ARTICLE; BEHAVIOR; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; COMPARATIVE STUDY; DRUG USE; EXERCISE; FAT INTAKE; FEMALE; HEALTH SURVEY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; POPULATION RESEARCH; QUESTIONNAIRE; RESIDENTIAL HOME; RISK FACTOR; RISK REDUCTION; SEX DIFFERENCE; STRATIFICATION; TELEPHONE; TREATMENT OUTCOME;

ASPIRIN; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; EXERCISE; FEMALE; FOOD HABITS; HEALTH BEHAVIOR; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; LIFE STYLE; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATIENT PARTICIPATION; PLATELET AGGREGATION INHIBITORS; POPULATION SURVEILLANCE; RISK FACTORS; RISK REDUCTION BEHAVIOR; SEX FACTORS; UNITED STATES;

EID: 3042512305     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amepre.2004.03.008     Document Type: Article

References (58)

1. American Heart Association. American Heart Association 2002 heart and stroke statistical update. Dallas TX: American Heart Association, 2001
2. Lenfant C., Chobanian A., Jones D., Roccella E. Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Seventh report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7) resetting the hypertension sails. Hypertension. 41:2003;1178-1179
3. Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 285:2001;2486-2497
4. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. 308:1994;81-106
5. U.S. Preventive Services Task Force. Screening for high blood pressure recommendations and rationale. Am J Prev Med. 25:2003;159-164
6. U.S. Preventive Services Task Force. Screening for lipid disorders recommendations and rationale. Am J Prev Med. 20:2001;73-76
7. U.S. Preventive Services Task Force. Aspirin for the primary prevention of cardiovascular events recommendations and rationale. Ann Intern Med. 136:2001;157-160
8. Smith S.J., Blair S., Bonow R., et al. AHA/ACC Scientific Statement AHA/ACC guidelines for preventing heart attack and death in patient with atherosclerotic cardiovascular disease: 2001 update: a statement for healthcare professionals from the American Heart Association and the American College of Cardiology. Circulation. 104:2001;1577-1579
9. Pearson T., Blair S., Daniels S., et al. AHA guidelines for the primary prevention of cardiovascular disease and stroke. 2002 Update Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. Circulation. 106:2002;388-391
10. Thompson P., Buchner D., Pina I., et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease a statement from the Council of Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommitee on Physical Activity). Circulation. 107:2003;3109-3116
11. Krauss R., Eckel R., Howard B., et al. AHA dietary guidelines. Revision 2000 a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation. 102:2000;2284-2299
12. Mosca L., Grundy S., Judelson D., et al. Guide to preventive cardiology for women. Circulation. 99:1999;2480-2484
13. Colwell J. Aspirin for primary prevention of cardiovascular events in diabetes. Diabetes Care. 26:2003;3349-3350
14. Qureshi A., Suri M., Guterman L., Hopkins L. Ineffective secondary prevention in survivors of cardiovascular events in the U.S. population report from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 161:2001;1621-1628
15. Saadine J., Engelgau M., Beckles G., Gregg E., Thompson T., Narayan K. A diabetes report card for the United States quality of care in the 1990s. Ann Intern Med. 136:2002;565-574
16. Stafford R. Aspirin use is low among United States outpatients with coronary artery disease. Circulation. 101:2000;1097-1101
17. Stafford R., Radley D. The underutilization of cardiac medications of proven benefit, 1990 to 2002. J Am Coll Cardiol. 41:2003;56-61
18. Egede L., Zheng D. Modifiable cardiovascular risk factors in adults with diabetes prevalence and missed opportunities for physician counseling. Arch Intern Med. 162:2002;427-433
19. Hyman D., Pavlik V. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 345:2001;479-486
20. Kim C, Hofer T, Kerr E. Review of evidence and explanations for suboptimal screening and treatment of dyslipidemia in women: a conceptual model. J Gen Intern Med 2003;18
21. Schulman K., Berlin J., Harless W., et al. The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med. 340:1999;618-626
22. Ayanian J., Epstein A. Differences in the use of procedures between women and men hospitalized for coronary heart disease. N Engl J Med. 325:1991;221
23. Ghali W., Faris P., Galbraith P., et al. Sex differences in access to coronary revascularization after cardiac catheterization importance of detailed clinical data. Ann Intern Med. 136:2002;723-732
24. Ayanian J., Landon B., Landrum M., Grana J., McNeil B. Use of cholesterol-lowering therapy and related beliefs among middle-aged adults after myocardial infarction. J Gen Intern Med. 17:2002;95-97
25. Mosca L., Jones W., King K., Ouyang P., Redberg R., Hill M. Awareness, perception, and knowledge of heart disease risk and prevention among women in the United States. American Heart Association Women's Heart Disease and Stroke Campaign Task Force. Arch Fam Med. 9:2000;506-515
26. Stafford R., Blumenthal D. Specialty differences in cardiovascular disease prevention practices. J Am Coll Cardiol. 32:1998;1238-1243
27. Stafford R., Blumenthal D., Pasternak R. Variations in cholesterol management practices of U.S. physicians. J Am Coll Cardiol. 29:1997;139-146
28. Corbie-Smith G., Flagg E., Doyle J., O'Brien M. Influence of usual source of care on differences by race/ethnicity in receipt of preventive services. J Gen Intern Med. 17:2002;458-464
29. Brown D., Giles W., Greenlund K., Croft J. Disparities in cholesterol screening falling short of a national health objective. Prev Med. 33:2001;517-522
30. Sloan K., Sales A., Willems J., et al. Frequency of serum low-density lipoprotein cholesterol measurement and frequency of results <100 mg/dl among patients who had coronary events (Northwest VA Network Study). Am J Cardiol. 88:2001;1143-1146
31. Miller M., Byington R., Hunninghake D., Pitt B., Furberg C. Sex bias and underutilization of lipid-lowering therapy in patients with coronary artery disease at academic medical centers in the United States and Canada. Arch Intern Med. 160:2000;343-347
32. Maviglia S., Teich J., Fiskio J., Bates D. Using an electronic medical record to identify opportunities to improve compliance with cholesterol guidelines. J Gen Intern Med. 16:2001;531-537
33. Pearson T., Laurora I., Chu H., Kafonek S. The Lipid Treatment Assessment Project (L-TAP). Arch Intern Med. 160:2000;459-467
34. Mustard C., Kaufert P., Kozyrskyj A., Mayer T. Sex differences in the use of healthcare services. N Engl J Med. 338:1998;1678-1683
35. State-specific trends in high blood cholesterol awareness among persons screened - United States, 1991-1999. MMWR Morb Mortal Wkly Rep 2001;50:754-8
36. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System 1999 survey data. Atlanta GA: National Center for Chronic Disease Prevention and Health Promotion, U.S. Department of Health and Human Services, 1999
37. Remington P., Smith M., Williamson D., Anda R., Gentry E., Hogelin G. Design, characteristics, and usefulness of state-based behavioral risk factor surveillance 1981-1987. Public Health Rep. 103:1988;366-375
38. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System user's guide. Atlanta GA: U.S. Department of Health and Human Services, 1998
39. Holtzman D., Powell-Griner E., Bolen J., Rhodes L. State- and sex-specific prevalence of selected characteristics - Behavioral Risk Factor Surveillance System, 1996 and 1997. MMWR Surveill Summ. 49:2000;1-39
40. Bowlin S., Morrill B., Nafziger A., Jenkins P., Lewis C., Pearson T. Validity of cardiovascular disease risk factors assessed by telephone survey the Behavioral Risk Factor Survey. J Clin Epidemiol. 46:1993;561-571
41. Zhang J., Yu K. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 280:1998;1690-1691
42. Centers for Disease Control and Prevention. Measuring healthy days. Centers for Disease Control and Prevention. Available at: www.cdc.gov/nccdphp/ hrqol/pdfs/mhd.pdf. Accessed August 8, 2003
43. Hennekens C., Dyken M., Fuster V. Aspirin as a therapuetic agent in cardiovascular disease a statement for healthcare professionals from the American Heart Association. Circulation. 96:1997;2751-2753
44. American Diabetes Association. American Diabetes Association aspirin therapy in diabetes (position statement). Diabetes Care. 23:2000;S61-62
45. American Diabetes Association. Aspirin therapy in diabetes. Diabetes Care. 24:2001;S62-63
46. American Diabetes Association. American Diabetes Association clinical practice recommendations 2001. Diabetes Care. 24:2001;S1-133
47. Krein S., Vijan S., Pogach L., Hogan M., Kerr E. Aspirin use and counseling about aspirin among patients with diabetes. Diabetes Care. 25:2002;965-970
48. Rolka D., Fagot-Campagna A., Narayan K. Aspirin use among adults with diabetes estimates from the Third National Health and Nutrition Examination Survey. Diabetes Care. 24:2001;197-201
49. Schwartz L., Fisher E., Tosteson N., et al. Treatment and health outcomes of women and men in a cohort with coronary artery disease. Arch Intern Med. 157:1997;1545-1551
50. Meigs J., Stafford R. Cardiovascular disease prevention practices by U.S. physicians for patients with diabetes. J Gen Intern Med. 15:2000;220-228
51. O'Connor P., Pronk N., Tan A., Rush W., Gray R. Does professional advice influence aspirin use to prevent heart disease in an HMO population? Eff Clin Pract. 1:1998;26-32
52. Henderson J., Weisman C., Grason H. Are two doctors better than one? Women's physician use and appropriate care. Womens Health Issues. 12:2002;138-149
53. Cooper G., Goodwin M., Stange K. The delivery of preventive services for patient symptoms. Am J Prev Med. 21:2001;177-181
54. Kravitz R., Hays R., Sherbourne C., et al. Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 153:1993;1869-1878
55. Centers for Disease Control and Prevention. Physician advice and individual behaviors about cardiovascular disease risk reduction-seven states and Puerto Rico, 1997. MMWR Morb Mortal Wkly Rep. 48:1999;74-77
56. Galuska D., Will J., Serdula M., Ford E. Are health care professionals advising obese patients to lose weight? JAMA. 282:1999;1576-1578
57. Kerr E., Krein S., Vijan S., Hofer T., Hayward R. Avoiding pitfalls in chronic disease quality measurement a case for the next generation of technical quality measures. Am J Manag Care. 7:2001;1033-1043
58. Harwell T., Moore K., Madison M., et al. Comparing self-reported measures of diabetes care with similar measures from a chart audit in a well-defined population. Am J Med Qual. 16:2001;3-8